PCa exhibits significant genomic heterogeneity, and alterations in tumor suppressor genes (TSGs), such as SPOP, TP53, PTEN, and RB1, have emerged as key players in disease development and progression. The gene discussed is PTEN; the disease is posterior cortical atrophy.